Dishman Carbogen Amcis Limited — Updates, 05-11-2025: Press Release
05-11-2025 | 07:11 pm
05-11-2025 | 07:11 pm
Dishman Carbogen Amcis Ltd's latest quarter revenue was 652.7 Cr, down due to CDMO shipment delays. However, half-year revenue increased to 1,360.7 Cr, boosted by development and marketable molecules. EBITDA margins significantly improved across both periods due to higher-margin products and cost cuts.
No comments yet. Be the first to comment!
